Submissions received by the Committee


Supply of chemotherapy drugs such as Docetaxel

Submissions received by the Committee

Sub No.

1Name Withheld (PDF 27KB) 
2Think Pharmacy Oxley (PDF 133KB) 
3Cabrini (PDF 1030KB) 
4The Wesley Pharmacy Group (PDF 56KB) 
5Sunshine Coast Haematology and Oncology Clinic (PDF 4222KB) 
6The Society of Hospital Pharmacists of Australia (PDF 428KB) 
7Northern Cancer Institute (PDF 2235KB) 
8Epworth HealthCare (PDF 1922KB) 
9Slade Pharmacy Services (PDF 332KB) 
10Joondalup Hospital Pharmacy (PDF 255KB) 
11Confidential
12Department of Health and Human Services Tasmania (PDF 137KB) 
13Pharmaceutical Society of Western Australia (PDF 234KB) 
14CanSpeak (PDF 160KB) 
Supplementary Submission(PDF 50KB) 
15Sydney Adventist Hospital, Adventist HealthCare (PDF 190KB) 
Supplementary Submission(PDF 401KB) 
16Clinical Oncological Society of Australia and Cancer Pharmacists Group (PDF 396KB) 
17Medical Oncology Group of Australia Inc. and Private Cancer Physicians of Australia (PDF 139KB) 
18Cancer Voices Australia (PDF 5084KB) 
Supplementary Submission(PDF 1002KB) 
19Integrated Clinical Oncology Network (ICON) (PDF 1313KB) Attachment 1(PDF 344KB) 
20Community Pharmacy Chemotherapy Services Group (PDF 279KB) Attachment 1(PDF 2651KB) Attachment 2(PDF 545KB) Attachment 3(PDF 959KB) 
21Mr John Jackson (PDF 56KB) 
22Consumers Health Forum of Australia (PDF 1531KB) 
23Ramsay Pharmacy Services  (PDF 153KB) 
24Australian Private Hospitals Assocation (PDF 142KB) 
25The Pharmacy Guild of Australia (PDF 6852KB) 
Supplementary Submission(PDF 182KB) 
26UnitingCare Health (PDF 141KB) 
27Medicines Australia (PDF 544KB) 
28Confidential
29Capital Chemist (PDF 56KB) 
30Name Withheld (PDF 966KB) 
31APHS Pharmacy Group (PDF 237KB) Attachment 1(PDF 61KB) 
Supplementary Submission(PDF 69KB) 
32Pharmaceutical Society of Australia Ltd (PDF 85KB) 
33Catholic Health Australia (PDF 292KB) 
34Confidential
35Department of Health and Ageing (PDF 864KB) 
36South Australian Government (PDF 525KB) 
37Confidential


Additional Information Received

1Tabled document from Society of Hospital Pharmacists of Australia, at Sydney public hearing 28 March 2013(PDF 371KB) 
2Tabled document from Slade Pharmacy Services, at Sydney public hearing 28 March 2013(PDF 965KB) 
3Tabled document from APHS Pharmacy Group, at Sydney public hearing 28 March 2013(PDF 417KB) 
4Tabled document from Northern Cancer Institute, at Sydney public hearing 28 March 2013(PDF 3784KB) 
5Tabled document from Northern Cancer Institute, at Sydney public hearing 28 March 2013(PDF 3659KB) 
6Tabled document from Northern Cancer Institute, at Sydney public hearing 28 March 2013(PDF 2196KB) 
7Tabled document from Northern Cancer Institute, at Sydney public hearing 28 March 2013(PDF 889KB) 
8Tabled document from Northern Cancer Institute, at Sydney public hearing 28 March 2013(PDF 7531KB) 
9Research paper presentation, from APHS Pharmacy Group, received 12 April 2013(PDF 2934KB) 
10Sustainable funding model, from Society of Hospital Pharmacists of Australia, received 11 April 2013(PDF 2770KB) 

Correspondence

1Correction from Society of Hospital Pharmacists of Australia to evidence given at Sydney public hearing 28 March 2013(PDF 67KB) 
2Correspondence from SA Health, received 4 April 2013(PDF 178KB) 

Answers to Questions on Notice

1Answers to Questions on Notice received from Northern Cancer Institute, 2 April 2013(PDF 69KB) 
2Answers to Questions on Notice received from Clinical Oncological Society of Australia, 3 April 2013(PDF 61KB) 
3Answers to Questions on Notice received from CanSpeak, 8 April 2013(PDF 132KB) 
4Answers to Questions on Notice received from Sydney Adventist Hospital, 8 April 2013(PDF 433KB) 

For further information, contact:

Committee Secretary
Senate Standing Committees on Community Affairs
PO Box 6100
Parliament House
Canberra ACT 2600
Australia

Phone:+61 2 6277 3515
Fax:+61 2 6277 5829
Email:community.affairs.sen@aph.gov.au